Experiment 67539

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismSerenoa repens (ARECACEAE)
CitationVACHEROT,F: AZZOUZ,M: DE MEDINA,SDD: COLOMBEL,M: TAILLE,ADL: BELDA,MAL: ABBOU,CC: RAYNAUD,JP: CHOPIN,DK:. (2000). INDUCTION OF APOPTOSIS AND INHIBITION OF CELL PROLIFERATION BY THE LIPIDO-STEROLIC EXTRACT OF SERENOA REPENS (LSESR, PERMIXON) IN BENIGN PROSTATIC HYPERPLASIA.. 45(3)
Amount utilized
Compound isolated
DiseaseA CLINICAL TRIAL WAS CONDUCTED TO ASSESS THE EFFECT OF SERENOA REPENS IN THE TREATMENT OF BPH. PATIENTS RECEIVED 320 MG OF LSESR FOR 3 MONTHS. RESULTS SHOWED LSESR INHIBITED CELL PROLIFERATION AND INDUCED CELL DEATH IN PROSTATE EPITHELIUM AND STROMA.
Dose amount320.0 MG
Number2
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractHEXANE EXT
GenderMALE